At the news
? NEUTRALIMPACT 3/10 144 filed Nov 9, 2026 at 16:21 ET
Bernard J Zovighian, an officer and director of Edwards Lifesciences, filed a Form 144 notice of intent to sell 46,200 shares of common stock with an approximate market value of $4.76 million. The shares are to be sold via a cashless exercise of employee stock options, with the sale to occur on or around November 9, 2026.
- Insider: Bernard J Zovighian (Officer and Director)
- Shares to be sold: 46,200 shares of common stock
- Approximate value: $4,759,559 (based on $103.02 per share implied by the filing)
- Sale method: Cashless exercise of employee stock options
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access